SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The March 2025 quarter revenue stood at Rs. 9013.40 millions, up 11.39% as compared to Rs. 8092.00 millions during the corresponding quarter last year.A slim rise of 19.03% was recorded in the Net profit for the quarter ended March 2025 to Rs. 1498.00  millions  From Rs. 1258.50 millions.Operating Profit saw a handsome growth to 2445.10 millions from 2111.50 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 9013.40 8092.00 11.39 37229.20 32986.40 12.86 37229.20 32986.40 12.86
Other Income 135.30 161.00 -15.96 347.40 346.80 0.17 347.40 346.80 0.17
PBIDT 2445.10 2111.50 15.80 10526.80 9141.00 15.16 10526.80 9141.00 15.16
Interest 9.30 83.20 -88.82 91.20 405.20 -77.49 91.20 405.20 -77.49
PBDT 2435.80 2028.30 20.09 10435.60 8735.80 19.46 10435.60 8735.80 19.46
Depreciation 444.10 397.20 11.81 1664.50 1352.40 23.08 1664.50 1352.40 23.08
PBT 1991.70 1631.10 22.11 8771.10 7383.40 18.79 8771.10 7383.40 18.79
TAX 493.70 372.60 32.50 2245.70 1949.80 15.18 2245.70 1949.80 15.18
Deferred Tax 57.80 93.40 -38.12 328.80 494.90 -33.56 328.80 494.90 -33.56
PAT 1498.00 1258.50 19.03 6525.40 5433.60 20.09 6525.40 5433.60 20.09
Equity 155.70 155.20 0.32 155.70 155.20 0.32 155.70 155.20 0.32
PBIDTM(%) 27.13 26.09 3.96 28.28 27.71 2.04 28.28 27.71 2.04

JB Chem & Pharma Share Price

1974.30 -3.70 (-0.19%)
16-Apr-2026 14:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1684.50
Dr. Reddys Lab 1224.65
Cipla 1230.15
Zydus Lifesciences 936.15
Lupin 2317.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×